{"id":"W2944338381","doi":"10.1158/1538-7445.sabcs18-p6-18-15","title":"Abstract P6-18-15: Ribociclib + endocrine therapy in hormone receptor-positive, HER2-negative advanced breast cancer: A pooled safety analysis","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Adverse effect; Letrozole; Fulvestrant; Anastrozole; Internal medicine; Common Terminology Criteria for Adverse Events; Breast cancer; Goserelin; Cancer; Placebo; Tamoxifen; Oncology; Gynecology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0141355,0.001798337,0.003749337,0.001780533,0.0002343942,0.001890848,0.0005950811,0.001013421,0.005414393],"category_scores_gemma":[0.01164811,0.0005948328,0.01235937,0.001896049,0.0004663155,0.000938758,0.001024896,0.001132295,0.0007818308],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007561121,"about_ca_system_score_gemma":0.001156596,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006531722,"about_ca_topic_score_gemma":0.0008942551,"domain_scores_codex":[0.9910794,0.005511895,0.001101448,0.0009109119,0.001177667,0.0002186946],"domain_scores_gemma":[0.9933792,0.002334911,0.002842393,0.0005301365,0.0006870192,0.0002261723],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.3905137,0.0009579298,0.02070494,0.01253241,0.4794498,0.000179159,0.00007759612,0.003917318,0.006394944,0.0002363807,0.005030356,0.08000546],"study_design_scores_gemma":[0.1427867,0.06199656,0.1037114,0.001363648,0.6603789,0.000718329,0.0001314345,0.006368469,0.005330731,0.001034716,0.01601571,0.0001633163],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7001562,0.219687,0.02185348,0.001405154,0.0008975589,0.007503885,0.03877728,0.0008231037,0.00889628],"genre_scores_gemma":[0.9661025,0.01660347,0.003177797,0.0007948938,0.0005489358,0.002263364,0.008579165,0.00007984651,0.001850083],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0141355,"threshold_uncertainty_score":0.07475656,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03212609355398043,"score_gpt":0.3930988829096352,"score_spread":0.3609727893556548,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}